Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

444

Participants

Timeline

Start Date

September 7, 2020

Primary Completion Date

March 18, 2021

Study Completion Date

August 1, 2021

Conditions

Typhoid Fever

Interventions

BIOLOGICAL

EuTCV (Vi-CRM Typhoid conjugate vaccine)

Single dose, Intramuscular administration

BIOLOGICAL

Typbar-TCV

Single dose, Intramuscular administration

Trial Locations (2)

De La Salle Medical and Health Sciences Institute, Cavite

University of the East Ramon Magsaysay Memorial Medical Center, Quezon City